A Study of MKC-442 in Combination With Other Anti-HIV Drugs

NCT00002412 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Emivirine
DRUG: Hydroxyurea
DRUG: Stavudine
DRUG: Didanosine

Sponsor

Triangle Pharmaceuticals